TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00397891

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bapineuzumab
Description: The dose cohorts are as follows: 0.15 mg/kg AAB-001; 0.5 mg/kg AAB-001; 1.0 mg/kg AAB-001. Placebo is vehicle (all ingredients except active). In each dose cohort, designated as groups 1 to 3, study drug (AAB-001 or placebo) will be administered as an intravenous infusion over 1 hour.
Study: NCT00112554

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cytarabine
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: laromustine
Description: Given IV

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: Given IV
Study: NCT04101994

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual cycling training
Description: Virtual cycling training is a convenient and easy approach for muscle strengthening.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual cycling training
Description: Virtual cycling training is a convenient and easy approach for muscle strengthening.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual cycling training
Description: Virtual cycling training is a convenient and easy approach for muscle strengthening.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual cycling training
Description: Virtual cycling training is a convenient and easy approach for muscle strengthening.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation
Description: Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Repetitive transcranial magnetic stimulation
Description: Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation
Description: TES is a constant current with low intensity delivered to the skull through surface electrodes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation
Description: TES is a constant current with low intensity delivered to the skull through surface electrodes.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial electric stimulation
Description: TES is a constant current with low intensity delivered to the skull through surface electrodes.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial electric stimulation
Description: TES is a constant current with low intensity delivered to the skull through surface electrodes.
Study: NCT04509206

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutritional education
Description: The curriculum for the four classes include understanding MyPlate guidelines, learn basic knife skills, meal prep, and plan, home farming and no-cook cooking.
Study: NCT03597659

Intervention type: GENETIC
Intervention: phenome-wide association study (PheWAS)
Description: Phenome-wide association study (PheWAS) identifying clinical diagnoses associated with a polygenic predictor of TSH levels identified by a previously published genome-wide association study (GWAS) which included North American and European participants. A phenome-wide scanning of 1,318 phenotypes will be performed, using a cohort of 37,154 North American individuals of European ancestry with electronic-health-record (EHR) data.
Study: NCT01102816

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individualized acupuncture treatment
Description: Individualized acupuncture treatment which focuses on each patient's symptoms and conditions will be provided twice a week for 6 weeks on a non-dialysis access day or before hemodialysis at dialysis-access day. 10-20 acupuncture needles will be inserted on the body except the arteriovenous fistula-located arm(s). Electrical stimulation of acupuncture will be conducted on 4 needles and the remained needles will be manipulated manually to elicit de-qi sensation. Needle retention time will be 20 minutes.~Routine care provided by dialysis staffs, primary physicians and other healthcare providers will be maintained.~Patients who received acupuncture treatment will be interviewed to explore patient's perceptions and experiences of acupuncture for their pain management. (Nested-qualitative study)

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: Routine care
Description: Patients in this group will maintain routine care provided by their dialysis staffs, primary physicians or other healthcare providers for symptomatic care and disease management of end-stage renal disease through 6 weeks. After post-treatment evaluation, acupuncture treatment will be provided to patients who want to receive acupuncture treatment.
Study: NCT00852124

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: VSL#3
Description: VSL#3 2 times daily
Study: NCT01342757

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vorinostat
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide
Description: Given orally

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: magnetic resonance spectroscopic imaging
Description: Undergo MRI

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: survey administration
Description: Ancillary studies
Study: NCT02548390

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RXDX-107
Description: Subjects in this study will receive RXDX-107 intravenously at dose levels specified for their respective dose cohorts. Dosing will begin at 25 mg/m2 on Day 1 and Day 2 of a 28-day cycle and will escalate until the maximum tolerated dose (MTD) or (RP2D) is determined. An additional schedule of administration of RXDX-107 on Day 1 of a 28 day cycle may be assessed. Cycles will be repeated in four-week (28 day) intervals for up to 6 cycles or until progression of disease, unacceptable toxicity, or another discontinuation criterion is met.
Study: NCT04573114

Intervention type: PROCEDURE
Intervention: Verticalization
Description: Progressive levels of verticalization

Intervention type: PROCEDURE
Intervention: Verticalization
Description: Progressive levels of verticalization
Study: NCT03353883

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triptorelin SR
Description: GnRH agonist depot( Decapeptyl) will be taken in the previous mid luteal cycle in group A and the first day in group B

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triptorelin SR
Description: GnRH agonist depot( Decapeptyl) will be taken in the previous mid luteal cycle in group A and the first day in group B
Study: NCT00738764

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PDL192
Description: Humanized anti-TWEAK receptor monoclonal IgG1 antibody

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PDL192
Description: Humanized anti-TWEAK receptor monoclonal IgG1 antibody

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PDL192
Description: Humanized anti-TWEAK receptor monoclonal IgG1 antibody

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PDL192
Description: Humanized anti-TWEAK receptor monoclonal IgG1 antibody

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PDL192
Description: Humanized anti-TWEAK receptor monoclonal IgG1 antibody
Study: NCT00235391

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Deferasirox
Description: 125 mg, 250 mg and 500 mg tablets. Dosage was calculated based on participant's body weight. Tablets were dispersed in water, orange or apple juice and taken orally once a day.
Study: NCT02845947

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: The music therapy intervention offered during the time of the patient's extubation readiness trial (ERT) will consist of live music using a multitude of instruments and patient-preferred and improvised music. The music therapy interventions will always include the use of live music, including guitar, keyboard, voice, ocean drum, reverie harp, and/or various percussive instruments. The music therapist will use a tablet to understand how to play patient-preferred songs. To ensure patient safety, the music therapist will adhere to the infection control policies set forth by the institution. The following are the intended goals of the Music therapy intervention: facilitating relaxation, alleviation of anxiety, and successful utilization of new coping skills.
Study: NCT03282773

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Deferred stent implantation
Description: Primary angiography and pretreatment including balloon dilatation and thrombus aspiration, second generation drug-eluting stents are implanted 4-10 days after restoration of blood flow in left main coronary artery in a secondary PCI.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Immediate stent implantation
Description: Primary angiography and pretreatment including balloon dilatation and thrombus aspiration, second generation drug-eluting stents are implanted immediately after restoration of blood flow in left main coronary artery in a secondary PCI.
Study: NCT03171246

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Solid food-based intervention
Description: Individually tailored energy content according to age/activity
Study: NCT04258995

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
Description: 2 formulations at 1 dose level

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)
Description: 2 formulations at 1 dose level
Study: NCT02372552

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CROMA
Description: Microwave coagulation of small blood vessels
Study: NCT03000777

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: melatonin plus zinc
Description: Melatonin 1 mg plus Zinc 10 mg o.d. 1 hour before going to bed during 16 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Isomaltose o.d. 1 hour before going to bed during 16 weeks
Study: NCT04092192

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IVC filter removal
Description: In the clinic, it will be explained to patient that they are asked to participate in a study that would randomize them to one of two established techniques for IVC filter removal. It will be explained these are both techniques that are used by interventional radiologists normally used for IVC filter retrieval.~One technique would be the utilization of an endovascular snare (like a lasso) device that is designed to catch the hook of the filter and allow it to be captured.~The other technique described will be the usage of a rigid forceps device that will be used to engage the filter apex directly and allow for the filter to be capture/removed.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: IVC filter removal
Description: In the clinic, it will be explained to patient that they are asked to participate in a study that would randomize them to one of two established techniques for IVC filter removal. It will be explained these are both techniques that are used by interventional radiologists normally used for IVC filter retrieval.~One technique would be the utilization of an endovascular snare (like a lasso) device that is designed to catch the hook of the filter and allow it to be captured.~The other technique described will be the usage of a rigid forceps device that will be used to engage the filter apex directly and allow for the filter to be capture/removed.
Study: NCT03000504

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ballooned intercostal drain
Description: Patients will have a Rocket Medical 16F ballooned intercostal drain inserted as per usual clinical guidelines. No other change to treatment will be made, and the drain is inserted in exactly the same way as a standard drain, using the Seldinger technique.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ballooned intercostal drain
Description: Patients will have a Rocket Medical 16F ballooned intercostal drain inserted as per usual clinical guidelines. No other change to treatment will be made, and the drain is inserted in exactly the same way as a standard drain, using the Seldinger technique.
Study: NCT00970450

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: Paracetamol 1 g i.v. once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: Paracetamol 1 g i.v. once

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tropisetron
Description: Tropisetron 5 mg i.v. once

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tropisetron
Description: Tropisetron 5 mg i.v. once

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline
Study: NCT01982006

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cataract surgery with Phacoemulsification
Description: Each patients randomized in the phaco arm will undergo a conventional cataract surgery.~Corneal incisions will be manually performed using the same calibrated blade and at the same location for all procedures of one surgeon.~Phacoemulsification machine used to perform cataract surgery in each center will be the same for all patients included in the center. The IOL (IntraOcular Lens) used in each center will be the same for all patients treated in the center.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted cataract surgery
Description: Each patients randomized in the femto arm will undergo a femtosecond laser assisted cataract surgery.~Corneal incisions will be performed by the laser. Number, size and location of the incisions must be the same than in the phaco arm for all patients treated by one surgeon.~Phacoemulsification machine used to remove the liquefied lens will be the same than in the phaco arm The IOL used in each center will be the same than in the phaco arm
Study: NCT03597178

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: senofilcon A
Description: ACUVUE OASYS® 1-DAY with HydraLuxe™ Technology
Study: NCT03234556

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy of Prostate
Description: Undergo SR-Bx

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy of Prostate
Description: Undergo SR-Bx

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: MRI Ultrasound Fusion Guided Biopsy
Description: Undergo MRUS-Bx

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI Ultrasound Fusion Guided Biopsy
Description: Undergo MRUS-Bx
Study: NCT04510883

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PACO
Description: The intervention is a fully-automated web-based eHealth application in which two embodied conversational agents engage in dialogue with older adults in order to motivate them towards dietary behavior change and decrease loneliness. The application consists of five different modules, each one applying different behavior change techniques.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waiting list + PACO
Description: Waiting list + PACO
Study: NCT02793830

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Daily reminders of taking medications
Description: Reminders. Participants will receive medication-taking reminders from the researcher. These reminders are sent through the mobile application-BB Reminder on an unencrypted external device (a phone borrowed from Duke University School of Nursing and is used specifically for this study by the researcher). BB Reminder has the function that after inputting a patient's phone number and prescriptions, participants can receive reminders through text messages of the name, dosage, function, and administration route for every dose of his/her medications. The daily reminders will be sent to participants 15 minutes before every dose of their medications.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational materials
Description: Educational materials. Participants will receive educational materials from the researcher. These educational materials will be sent through the mobile application-WeChat. The educational materials include short articles (\< 500 words) and/or pictures. They will be retrieved from the Chinese Cardiovascular Disease-Prevention Information Website (www.healthyheart-china.com), which is governed by the Chinese Ministry of Health. The validity of information from it is guaranteed. The retrieved educational materials will be screened by the cardiologist, the head nurse, and the researcher, before sending to participants. The educational materials will be sent to participants every other day at any time during 8 am and 10 pm.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational materials
Description: Educational materials. Participants will receive educational materials from the researcher. These educational materials will be sent through the mobile application-WeChat. The educational materials include short articles (\< 500 words) and/or pictures. They will be retrieved from the Chinese Cardiovascular Disease-Prevention Information Website (www.healthyheart-china.com), which is governed by the Chinese Ministry of Health. The validity of information from it is guaranteed. The retrieved educational materials will be screened by the cardiologist, the head nurse, and the researcher, before sending to participants. The educational materials will be sent to participants every other day at any time during 8 am and 10 pm.
Study: NCT03327376

Intervention type: DEVICE
Intervention: ultrasound-screening
Description: Daily ultrasound-screening for CVC-related thrombosis (DUCT) by compression ultrasound and color doppler ultrasound.
Study: NCT01745523

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Synthetic macromolecule HPC and trehalose
Description: Oocytes are vitrified using the synthetic macromolecule HPC and trehalose

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SSS containing HSA and sucrose
Description: • Oocytes are vitrified using the SSS containing HSA and sucrose
Study: NCT02488213

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional Counseling
Description: The patients with type 2 diabetes mellitus treated in Endocrinology Division, Hospital de Clinicas de Porto Alegre will receive nutritional counseling from the diet quality assessment with adopting some techniques of motivational interviewing, and delivery of educational support material. The patients will need to come to hospital for three more visits every two months throughout the study (2, 4, 6 months). They will also be contacted by telephone during the months when will not have query (1, 3 and 5 months). The study will total duration of six months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual Diet Guidance
Description: The patients with type 2 diabetes mellitus treated in Endocrinology Division, Hospital de Clinicas de Porto Alegre will receive usual diet guidance from the current nutritional recommendations for diabetes, according to the routine performed. The patients will need to come to hospital for three more visits every two months throughout the study (2, 4, 6 months). They will also be contacted by telephone during the months when will not have query (1, 3 and 5 months). The study will total duration of six months.
Study: NCT01185964

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Olaratumab
Description: Olaratumab 15 mg/kg by intravenous transfusion (I.V.) on days 1+8 of a 21-day cycle

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Olaratumab
Description: Olaratumab 15 mg/kg by intravenous transfusion (I.V.) on days 1+8 of a 21-day cycle

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin
Description: Doxorubicin 75 mg/m2 by intravenous injection on day 1 of the 21-day cycle.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxorubicin
Description: Doxorubicin 75 mg/m2 by intravenous injection on day 1 of the 21-day cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: doxorubicin
Description: Doxorubicin 75 mg/m2 by intravenous injection on day 1 of the 21-day cycle.
Study: NCT00549029

Intervention type: GENETIC
Intervention: DNA
Description: withdraw 5\~10mL blood from vein only once during the whole design
Study: NCT03054597

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Circular light motion
Description: Exercise with circular light motion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Circular light motion
Description: Exercise with circular light motion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diagonal light motion
Description: Exercise with diagonal light motion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Diagonal light motion
Description: Exercise with diagonal light motion

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Peripheral light motion
Description: Exercise with peripheral light motion

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise
Study: NCT02486991

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tunnel + AlloDerm®
Description: A coronally positioned tunnel (CPT) technique for root coverage will be used alone with acellular dermal matrix (AlloDerm®).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tunnel + AlloDerm®
Description: A coronally positioned tunnel (CPT) technique for root coverage will be used alone with acellular dermal matrix (AlloDerm®).

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Tunnel + AlloDerm® + Verticals
Description: The use of intramucosal vertical incisions in addition to a coronally positioned tunnel (CPT) technique for root coverage will be used with acellular dermal matrix (AlloDerm®).